CLSD – clearside biomedical, inc. (US:NASDAQ)
Stock Stats
News
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Clearside Biomedical Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its price target lowered by analysts at Needham & Company LLC from $6.00 to $4.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13G Clearside Biomedical, Filed by: Wiles Stephen Boyd
Form 10-K Clearside Biomedical, For: Dec 31
Form 8-K Clearside Biomedical, For: Mar 27
Form SCHEDULE 13G/A Clearside Biomedical, Filed by: WHITMORE BRADFORD T
Form 4 Clearside Biomedical, For: Feb 24 Filed by: Thorp Clay
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.